MedPath

Suprapubic Single-incision Laparoscopic Appendectomy Versus Conventional Appendectomy: a Randomized Controlled Trial

Not Applicable
Conditions
Complications
Interventions
Procedure: suprapubic single-incision laparoscopic appendectomy
Registration Number
NCT02499016
Lead Sponsor
Nanfang Hospital, Southern Medical University
Brief Summary

Conventional laparoscopic appendectomy(CLA) is the current standard treatment. To obtain additional benefits such as a better cosmetic outcome, the investigators developed a surgical option termed suprapubic single-incision laparoscopic appendectomy (SSILA), which creates a non-visible scar, that was preliminarily shown to be feasible and safe in our previous retrospective studies To further evaluate the feasibility, safety and cosmetic results of this innovative approach, the investigators compared the outcomes of SSILA and CLA by performing a randomized controlled trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
208
Inclusion Criteria
  • acute appendicitis or interval appendicitis
  • informed consent
Exclusion Criteria
  • diagnosis of appendicitis was not clinically established (symptoms attributable to urinary or gynecological problems)
  • history of cirrhosis and coagulation disorders
  • suspected or proven malignancy
  • contraindication to general anesthesia (severe cardiac and/or pulmonary disease)
  • inability to give informed consent(severe mental disease)
  • pregnancy
  • BMI>30kg/m2
  • generalized peritonitis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
suprapubic single-incision laparoscopic appendectomysuprapubic single-incision laparoscopic appendectomysingle incision laparoscopic surgery will be performed for patients in this group.
conventional multiport appendectomysuprapubic single-incision laparoscopic appendectomyConventional laparoscopic surgery will be performed for patients in this group.
Primary Outcome Measures
NameTimeMethod
incidence of complications30 days

The early morbidity rate is defined as the event observed during operation and within 30 days after surgery

Secondary Outcome Measures
NameTimeMethod
mortality rate30 days
operative timeintraoperative
time to recover14 days
Pain score14 days

Postoperative pain is recorded using the visual analog scale (VAS) pain score tool on postoperative day 1, 2, 3 and the day of discharge.

cosmetic results30 days

Cosmetic assessment is perform using body image scale and cosmetic scale.

Trial Locations

Locations (1)

Nanfang Hospital, Southern Medical University

🇨🇳

Guangzhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath